Basics |
Innovus Pharmaceuticals Inc
|
IPO Date: |
March 4, 2021 |
Sector: |
Healthcare |
Industry: |
Medical Care Facilities |
Market Cap: |
$725.66M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.21 | 3.10%
|
Avg Daily Range (30 D): |
$0.21 | 4.13%
|
Avg Daily Range (90 D): |
$0.16 | 3.63%
|
Institutional Daily Volume |
Avg Daily Volume: |
.14M |
Avg Daily Volume (30 D): |
.04M |
Avg Daily Volume (90 D): |
.03M |
Trade Size |
Avg Trade Size (Sh.): |
101 |
Avg Trade Size (Sh.) (30 D): |
88 |
Avg Trade Size (Sh.) (90 D): |
82 |
Institutional Trades |
Total Inst.Trades: |
117 |
Avg Inst. Trade: |
$2.6M |
Avg Inst. Trade (30 D): |
$.67M |
Avg Inst. Trade (90 D): |
$.67M |
Avg Inst. Trade Volume: |
.15M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$4.86M |
Avg Closing Trade (30 D): |
$.67M |
Avg Closing Trade (90 D): |
$.67M |
Avg Closing Volume: |
246.33K |
|
|
Financials |
|
TTM |
Q4 2025 |
FY 2025 |
Basic EPS
|
$-.22
|
$
|
$-.22
|
Diluted EPS
|
$-.22
|
$
|
$-.22
|
Revenue
|
$ 853.7M
|
$ 221.42M
|
$ 853.7M
|
Gross Profit
|
$ 153.64M
|
$ 41.29M
|
$ 153.64M
|
Net Income / Loss
|
$ -35.34M
|
$ -5.01M
|
$ -35.34M
|
Operating Income / Loss
|
$ -29.76M
|
$ -2.15M
|
$ -29.76M
|
Cost of Revenue
|
$ 268.91M
|
$ 71.96M
|
$ 268.91M
|
Net Cash Flow
|
$ 8.23M
|
$ 4.73M
|
$ 8.23M
|
PE Ratio
|
|
|
|
Splits |
Mar 18, 2019:
1:105
|
|
|
|